Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/1999
11/25/1999WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332531A1 Protease inhibitors
11/25/1999CA2332492A1 Protease inhibitors
11/25/1999CA2332450A1 Esterified and subsequently hydrogenated phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
11/25/1999CA2332444A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation
11/24/1999EP0958828A1 Artichoke containing preparation especially for use as medicaments or nutritional supplement
11/24/1999EP0958816A2 Medicament for the treatment of diabetes mellitus as well as its subsequent disorders
11/24/1999EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/24/1999EP0958357A2 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/24/1999EP0958296A1 Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
11/24/1999EP0958280A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
11/24/1999EP0957923A1 Sulfonylurea-glitazone synergistic combinations for diabetes
11/24/1999EP0957911A1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
11/24/1999EP0957909A1 Use of nitric oxid synthase inhibitors for the treatment of diabetes
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0495091B1 Aica riboside analogs
11/24/1999CN1236361A N-substituted 2-cyanopyrodlidines
11/24/1999CN1046735C Steroids for treating menopausal complaints
11/24/1999CN1046731C Pyrrolo [2,3-d] pyrimidines and their use
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/23/1999US5990329 Retinoids
11/23/1999US5990173 Anticholesterol agents; treating atherosclerosis; enzyme inhibitors of acylcoenzyme a:cholesterol acyltransferase (acat)
11/23/1999US5990150 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
11/23/1999US5990139 Thiazolidinedione derivatives or salts thereof and pharmaceutical compositions containing the same
11/23/1999US5990103 Treating psoriasis by topical adminstration of pentoxifylline and diltiazem to a patient; a combination of a compound having a phosphodiesterase-inhibiting action, and a compound which reduces the intracellular calcium content
11/23/1999US5990102 Substituted azetidin-2-ones for treatment of atherosclerosis
11/23/1999US5990077 Glp-2 acts as a trophic agent to promote growth of gastrointestinal tissue, particularly increased growth of the small intestine and pancreatic islet; pharmaceutical compositions; treating diabetes
11/23/1999US5989551 Materials and methods for detection and treatment of insulin-dependent diabetes
11/23/1999CA1340829C Cloned dna for synthesizing unique glucocerebrosidase
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058533A1 Phenylurea and phenylthio urea derivatives
11/18/1999WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058522A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999WO1999058521A1 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058520A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058519A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058518A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058514A1 (2-acylaminothiazole-4-yl)acetic acid derivatives
11/18/1999WO1999058511A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058510A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058497A1 Substituted guanidines and diaminonitroethenes, their preparation and use
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058487A1 New compounds, their preparation and use
11/18/1999WO1999058486A1 New compounds, their preparation and use
11/18/1999WO1999058127A1 Novel heterocyclic analogs of diphenylethylene compounds
11/18/1999WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
11/18/1999WO1999058122A1 Novel fatty analogues for the treatment of diabetes
11/18/1999WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
11/18/1999WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
11/18/1999WO1999051271A3 Compositions comprising glycol derivatives and alcohols
11/18/1999WO1999050239A3 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999037682A3 Antibodies against human il-12
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999CA2331879A1 Oxyiminoalkanoic acid derivatives
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331735A1 Phenylurea and phenylthio urea derivatives
11/18/1999CA2331299A1 Substituted guanidines and diaminonitroethenes, their preparation and use
11/18/1999CA2331120A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2331118A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330623A1 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330599A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330558A1 (2-acylaminothiazole-4-yl)acetic acid derivatives
11/18/1999CA2330557A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330555A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0956862A1 Methods of increasing lean tissue mass using ob protein compositions
11/17/1999EP0956856A2 Calcium assimilation accelerator, calcium supplementing diet and method for accelerating calcium assimilation
11/17/1999EP0956302A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
11/17/1999EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999CN1235603A N-substituted azaheterocyclic compounds
11/17/1999CN1235553A Use of GLP-1 or analogs in treatment of myocardial infraction
11/17/1999CN1235552A Beta-glucan products and extration from cereals thereof
11/17/1999CN1235551A Pharmaceutical composition for diabetes
11/17/1999CN1235548A Method for lowering plasma levels of lipoprotein (A)
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235021A Composition for treating and preventing sudden death of chicken
11/16/1999US5986131 RXR selective ligands
11/16/1999US5986068 Luetinizing hormone, follicle stimulating hormone, thyroid stimulating hhormone and chronic gonadotropin linked with oligosaccharide
11/16/1999US5986052 Fusion polypeptide containing fragments of cartilage matrix protein and link protein
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985897 Benzothiphene compounds, intermediates, compositions, and methods
11/16/1999US5985873 Useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to human neuropeptide y1
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999US5985296 Complexes of gamma-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use
11/16/1999US5985282 St. john's wort (hypercin) and mahuang (ephedra sinica or ephedrine)
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
1 ... 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 ... 1298